Friday, March 29, 2024
ADVT 
International

Virus variant from South Africa detected in US for 1st time

Darpan News Desk The Canadian Press, 28 Jan, 2021 07:08 PM
  • Virus variant from South Africa detected in US for 1st time

A new coronavirus variant identified in South Africa has been found in the United States for the first time, with two cases diagnosed in South Carolina, state health officials said Thursday.

The arrival of this variant now surging in other countries "is an important reminder to all South Carolinians that the fight against this deadly virus is far from over,” Dr. Brannon Traxler, DHEC Interim Public Health Director, said in a statement. “While more COVID-19 vaccines are on the way, supplies are still limited. Every one of us must recommit to the fight by recognizing that we are all on the front lines now. We are all in this together.”

Viruses are constantly mutating, with coronavirus variants circulating around the globe, but scientists are primarily concerned with the emergence of three of them. Other variants first reported in the United Kingdom and Brazil were previously confirmed in the U.S. Researchers believe these three variants may spread more easily, and predicted it was only a matter of time before they appeared here.

Also, scientists last week reported preliminary but troubling signs that some of the recent mutations may modestly curb the effectiveness of two current vaccines, although they stressed that the shots still protect against the disease. And there are signs that some of the new mutations may undermine tests for the virus and reduce the effectiveness of certain treatments.

The coronavirus has already sickened millions and killed more than 400,000 people in the United States.

While some European countries do extensive genetic testing to detect these variants, the U.S. has done very little of this detective work. But scientists have been been quickly trying to do more, and they're spotting these apparently more contagious variants as they do.

The U.S. Centers for Disease Control and Prevention has reported at least 315 cases of the U.K.-discovered variant in the United States. Those reports have come from at least 28 states, and health officials believe it could become the dominant strain in the U.S. by March. That variant has been reported in at least 70 countries.

The first U.S. case of the variant found in Brazil was announced earlier this week by health officials in Minnesota. It was a person who recently travelled to that South American nation. That version of the virus has popped up in more than a half-dozen countries.

The variant first found in South Africa was detected in October. It since then has been found in at least 30 other countries.

Some tests suggest the South African and Brazilian variants may be less susceptible to antibody drugs or antibody-rich blood from COVID-19 survivors, both of which help people fight off the virus.

Health officials also worry that if the virus changes enough, people might get COVID-19 a second time.

President Joe Biden on Monday reinstated COVID-19 travel restrictions on most non-U.S. travellers from Brazil, the U.K. and South Africa. And the Centers for Disease Control and Prevention is recommending that Americans do not travel at this time.

MORE International ARTICLES

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US